Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
MELBOURNE,Australia,Aug. 28,2024--Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company) today announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Ad